Fluidigm Achieves Initial Milestone under NIH Rapid Acceleration of Diagnostics Agreement
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision […]
ChemoCentryx to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
MOUNTAIN VIEW, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., […]
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
Opaganib completely inhibited SARS-CoV-2 viral replication as measured after three days incubation in an in vitro model of human bronchial […]
AquaBounty Technologies to Present at Upcoming Investor Conferences in September
MAYNARD, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture […]
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
SAN DIEGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage […]
